The nature of this variant apparently results from tumor suppressor synergism compared to WWOX or AP-2α overexpression alone: i.e. processes that are not regulated by WWOX itself are manifested by AP-2α and vice versa. The gene discussed is WWOX; the disease is neoplasm.